Ranbaxy inks pact with Cipher to sell acne drug in Brazil
Drug major Ranbaxy today said it has inked a licensing pact with Canada's Cipher Pharmaceuticals Inc to exclusively market its isotretinoin capsules, used to treat acne, in Brazil.
Jul 24, 2014, 23:17 PM IST